Open AccessSystemic Therapy for Recurrent Epithelial Ovarian Cancer: A Clinical Practice Guideline
Author(s) -
JulieAnn Francis,
N. Coakley,
Laurie Elit,
Helen Mackay
Publication year - 2017
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.24.3824
Subject(s) - medicine , guideline , bevacizumab , olaparib , ovarian cancer , oncology , clinical trial , randomized controlled trial , context (archaeology) , intensive care medicine , cancer , gynecology , chemotherapy , pathology , paleontology , biochemistry , chemistry , biology , polymerase , poly adp ribose polymerase , gene
The purpose of this guideline is to recommend systemic therapy options for women with recurrent epithelial ovarian cancer, including fallopian tube and primary peritoneal cancers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom